Market-Moving News for October 30th

Day One Biopharmaceuticals, Inc. 0.00% Pre
Deciphera Pharmaceuticals Delist Pre
VYNE Therapeutics Inc -1.77% Pre

Day One Biopharmaceuticals, Inc.

DAWN

21.46

21.46

0.00%

0.00% Pre

Deciphera Pharmaceuticals

DCPH

25.59

25.59

Delist

0.00% Pre

VYNE Therapeutics Inc

VYNE

0.59

0.59

-1.77%

0.00% Pre

DCPH: 38% | Deciphera Pharma shares are trading higher after the company announced its study of patients with TGCT met its primary and secondary endpoint.

DAWN: 9.5% | Day One Biopharmaceuticals shares are trading higher after the company announced the FDA accepted its NDA for tovorafenib in relapsed or progressive pediatric low-grade glioma, granted priority review and assigned a PDUFA date of April 30, 2024.

VYNE: 72% | VYNE Therapeutics shares are trading higher after the company announced a private placement of $88 million and data from its Phase 1b trial evaluating once-daily dosing of VYN201 in patients with nonsegmental vitiligo.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.